Thiol-Functionalising Reagents for Site-Specific Protein PEGylation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pegylation methods for modifying proteins are uncontrolled, leading to heterogeneous products due to the use of reactive cross-linkers like maleimide, which react unpredictably with multiple functional groups, and glycosylation is rarely achieved in prokaryotic hosts, affecting the properties and stability of therapeutic polypeptides.
Innovation Solution
The use of nitrogen-containing heterocyclic aromatic rings with vinyl substituents covalently linked to poly(alkylene glycol) molecules or glycan groups, which react specifically with thiol groups in proteins to form stable thioether bonds, allowing for controlled modification and site-specific glycosylation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If reactive cross-linkers like maleimide are used for pegylation, then the polypeptide can be modified to improve stability and half-life, but the reaction becomes uncontrolled producing heterogeneous products
Solution Approach 1:
The patent introduces a site-specific thiol group as an intermediary target for PEGylation. Instead of allowing the cross-linker to react randomly with multiple functional groups, the thiol group serves as a specific mediator that directs the PEG attachment to a predetermined location on the polypeptide, ensuring both stability improvement and product homogeneity
Solution Approach 2:
The invention applies local quality by creating a specific reactive site (thiol group) at a particular location on the polypeptide chain. This localized reactive group ensures that PEGylation occurs only at the desired position rather than throughout the entire molecule, producing homogeneous products with consistent pharmacokinetic properties
2Adaptability or versatility
If PEG molecules react with multiple functional groups in polypeptides, then more extensive modification can be achieved, but the resulting products have variable structures and properties
Solution Approach 1:
The patent extracts the reactivity from multiple functional groups and concentrates it in a single thiol group. By introducing or utilizing one specific cysteine residue with a thiol group, the method takes out the indiscriminate reactivity of multiple groups and channels all PEGylation activity through this single controlled site, achieving both extensive modification and structural consistency
3Manufacturing precision
If protecting groups are used to control reaction site, then site-specific modification can be achieved, but the process becomes complex and difficult to implement in prokaryotic systems
Solution Approach 1:
The patent employs self-service by utilizing the polypeptide's own thiol group (either naturally present or introduced via site-directed mutagenesis) as the reactive site for PEGylation. This eliminates the need for external protecting groups and complex multi-step protection/deprotection sequences, significantly simplifying the process while maintaining high site specificity, especially in prokaryotic expression systems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise and controlled modification of proteins, improving their stability, biological half-life, and immunological properties, while allowing for glycosylation in prokaryotic hosts, resulting in more consistent and effective therapeutic polypeptide products.
Implementation Method 1
the vinyl substituent of the functionalising reagent reacts with the thiol group of the polypeptide, thereby to covalently link the poly(alkylene glycol) molecule to the polypeptide
Data Source
Figure 1~2
Figure 3~4
Figure 5A~6
AI summary
Reagents and methods for functionalising polypeptides with moieties poly(alkylene glycol) molecules and glycan groups are disclosed that are based on a functionalising reagent which comprises a nitrogen containing heterocyclic aromatic ring having a vinyl substituent that is capable of reacting with one or more thiol groups that are naturally present, or have been introduced into, the polypeptide, for example by employing a thiol group of one or more cysteine residues. The functionalising reagent is covalently linked to a poly(alkylene glycol) molecule, such as a polyethylene glycol (PEG) molecule, or a glycan group so that the reaction between the vinyl group and the thiol group in the polypeptide covalently links the polypeptide to the poly(alkylene glycol) molecule and/or the glycan group.